目錄:MedChemExpress LLC>>生化試劑>> CA-170 | MCE
CAS | 1673534-76-3 | 純度 | 99.39% |
---|---|---|---|
分子量 | 360.32 | 分子式 | C??H??N?O? |
供貨周期 | 現貨 | 規(guī)格 | 5 mg |
貨號 | HY-101093 | 應用領域 | 醫(yī)療衛(wèi)生,化工,生物產業(yè),制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,,我們不為任何個人用途提供產品和服務。
CAS No. : 1673534-76-3
產品活性:CA-170 is an orally delivered dual inhibitor of VISTA and PD-L1. CA-170 exhibits potent rescue of proliferation and effector functions of T cells inhibited by PD-L1/L2 and VISTA with selectivity over other immune checkpoint proteins as well as a broad panel of receptors and enzymes.
研究領域:Immunology/Inflammation
作用靶點:PD-1/PD-L1
In Vitro: CA-170 exhibits potent functional activity in rescuing T-cell proliferation and effector functions, while showing selectivity against other immune checkpoint proteins as well as in a broad panel of receptors and enzymes.
相關產品:Clinical Compound Library Plus | Bioactive Compound Library Plus | Peptidomimetic Library | Rulonilimab | PD-1/PD-L1-IN-19 | [D-Leu-4]-OB3 | NSC622608 | Sulindac | BMS-1166 | PD-1/PD-L1-IN-18 | Pacmilimab | Anti-Mouse PD-L1 Antibody | Vudalimab | PD-1/PD-L1-IN-24 | Cetrelimab | Human PD-L1 inhibitor III | PD-1/PD-L1-IN-20 | PD-1-IN-20 | PD-1/PD-L1-IN 5 | Sintilimab | PD-1/PD-L1-IN-9 hydrochloride | Nivolumab | PD-1/PD-L1-IN-16 | WL12 | PD-1/PD-L1-IN 6 | Acasunlimab | PD-1/PD-L1-IN-14 | PD1-PDL1-IN 1 | Sugemalimab | MAX-10181 | PD-1/PD-L1-IN-23 | D18
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,,我們致力于為*科研客戶提供前沿的高品質小分子活性化合物,;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產品種類涵蓋各種重組蛋白,,多肽,,常用試劑盒 ,更有 PROTAC,、ADC 等特色產品,,廣泛應用于新藥研發(fā)、生命科學等科研項目,;
• 提供虛擬篩選,,離子通道篩選,代謝組學分析檢測分析,,藥物篩選等專業(yè)技術服務,;
• 設有專業(yè)的實驗中心和嚴格的質控、驗證體系,;
• 提供 LC/MS,、NMR、HPLC,、手性分析,、元素分析等各項質檢報告,確保產品的高純度,、高品質,;
• 產品的生物活性多經各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機構建立了長期的合作,。